GSK plc Cost Of Inventories Recognised As Expense During Period
GSK plc (GLAXF) reported Cost Of Inventories Recognised As Expense During Period of GBP 6.36 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Expense Statement › Cost of Sales
ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod · last filed 2026-03-06
| Period end | Cost Of Inventories Recognised As Expense During Period 12 month | Cost Of Inventories Recognised As Expense During Period 12 month as first filed |
|---|---|---|
| 2025-12-31 | 6.36B GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | 6.50B GBP 20-F · filed 2026-03-06 | |
| 2023-12-31 | 6.58B GBP 20-F · filed 2026-03-06 | |
| 2022-12-31 | 6.14B GBP 20-F · filed 2025-03-03 | |
| 2021-12-31 | 5.88B GBP 20-F · filed 2024-03-05 | 9.19B GBP 20-F · filed 2022-03-08 |
| 2020-12-31 | 5.93B GBP 20-F · filed 2023-03-10 | 9.48B GBP 20-F · filed 2021-03-12 |
| 2019-12-31 | 9.48B GBP 20-F · filed 2022-03-08 | |
| 2018-12-31 | 8.71B GBP 20-F · filed 2021-03-12 | |
| 2017-12-31 | 8.53B GBP 20-F · filed 2020-03-06 | |
| 2016-12-31 | 8.09B GBP 20-F · filed 2019-03-15 | |
| 2015-12-31 | 7.60B GBP 20-F/A · filed 2018-03-20 |